USING OF 3-ARYLISOCOUMARINS IN 3-ARYLISOQUINOLONS SYNTHESIS

UDC 547.814.5, 547.833.7

Authors

Keywords:

3-arylisocoumarins (3-aryl-1H-isochromen-1-ones), 3-arylisoquinolones (3-arylisoquinolin-1(2H)-ones), recyclization, N-nucleophiles

Abstract

The review systematizes and analyzes the literature data (100 sources) regarding the recyclization of 3-arylisocoumarins (3-aryl-1H-isochromen-1-ones) under the action of primary N-nucleophiles that leads to the formation of 3-arylisoquinolones (3-arylisoquinolin-1(2H)-ones).

This reaction may be carried out with a wide range of primary aminogroup-containing compounds: ammonia, primary aliphatic, aromatic, and heteroaromatic amines, hydrazine, and hydroxylamine. This transformation is not hindered by the presence of active functional groups (hydroxyl, acetal, carboxyl, ester, nitrile groups, or additional aminogroup) neither in 3-arylcoumarin nor in the primary amine.

A special attention has been paid to reaction conditions (temperature regime, duration, solvent, catalysts), which may vary greatly. In particular, it is pointed out that in most cases to carry out high-temperature recyclization of 3-arylisocoumarins with ammonia and volatile amines with low molecular weight the use of closed reactors and high-pressure flasks was required.

The cases of successful recyclization of 11,12-dihydrodibenzo[c,h]chromen-6-ones, indeno[1,2-c]isochromen-5(11H)-ones, isochromeno[4,3-c]chromen-6,11-dione and 5H-benzofuro[3,2-c]isochromen-5-one are reviewed separately. The polycondensated heterocyclic system of these compounds contains a 3-arylisocoumarin fragment.

The biological activity data is presented for the compounds obtained via this transformation – 3-arylisoquinolin-1(2H)-ones, and also polycondensated systems that contain this fragment, e.g. 11,12-dihydrobenzo[c]phenanthridin-6(5H)-ones and 6H-indeno[1,2-c]isoquinoline-5,11-diones.

The opportunities to use 3-arylisoquinolin-1(2H)-ones in the synthesis of other compounds of isoquinoline family, e.g. natural benzo[c]phenanthridinealocoloids, are demonstrated.

References

1. Joule J.A., Mills K. Heterocyclic Chemistry. John Wiley & Sons, 2013, 720 p.

2. Isoquinolines. Part 1. Ed. Grethe G. John Wiley & Sons, 2009, 561 p.

3. Slotta K.H., Haberland G. Angew. Chem., 1933, 46 (49), 766–771.

4. Gabriel S., Neumann A. Chem. Ber., 1892, 25, 3563–3573.

5. Gabriel S. Chem. Ber., 1885, 18 (2), 3470–3480.

6. Harper C.A. Chem. Ber., 1896, 29, 2543–2549.

7. Farbwerke vorm. Meister Lucius & Brüning in Höchst a. M. Patent DE69138, 1893.

8. Barnard I.F., Elvidge J.A. J. Chem. Soc., 1983, 19, 1813–1818.

9. Powell B.F., Overberger C.G., Anselme J.-P. J. Het. Chem., 1983, 20 (1), 121–128.

10. Sakamoto T., An-naka M., Kondo Y., Yamanaka H. Chem. Pharm. Bull., 1986, 34 (7), 2754–2759.

11. Manivel P., Nawaz Khan F., Hatwar V.R. Phosphorus Sulfur Silicon Relat. Elem., 2010, 185 (9), 1932–1942.

12. Fan X., He Y., Cui L., Guo S., Wang J., Zhang X. Eur. J. Org. Chem., 2012, 4, 673–677.

13. Woon E.C.Y., Sunderland P.T., Paine H.A., Lloyd M.D., Thompson A.S., Threadgill M.D. Med. Chem., 2013, 21 (17), 5218–5227.

14. Threadgill M.D., Lloyd M.D., Thompson A.S., Nathubhai A., Wood P.J., Paine H.A., Kumpan E., Sunderland P.T., Chue Yen Woon E. Patent WO 2014087165 A1, 2014.

15. Johansson J.O., Hansen H.C., Chiacchia F.S., Wong N.C.W. Patent WO 2007016525 A2. 2007.

16. Wong N.C.W., Tucker J.E.L., Hansen H.C., Chiacchia F.S., McCaffrey D. Patent US2008188467, 2008.

17. McLure K.G., Young P.R. Patent WO2013156869A1 (US 2013281397 A1), 2013.

18. Minami T., Nishimoto A., Nakamura Y. Chem. Pharm. Bull., 1994, 42(8), 1700–1702.

19. Azimova S.S.,Yunusov M.S. Natural Compounds. Alkaloids. Plant Sources, Structure and Properties. Springer, Dordrecht, Heidelberg, London, New York, 2013, 780 p.

20. Minami T., Nishimoto A., Hanaoka M. Tetrahedron Lett., 1995, 36(52), 9505–9508.

21. Fang S.-D., Wang L.-K., Hecht S.M.J. Org. Chem., 1993, 58, 5025–5027.

22. Dusemund J. Arch. Pharm., 1977, 310, 846.

23. Mashelkar U.C., Usgaonkar R.N. Ind. J. Chem., Sect. B, 1977, 15, 926–992.

24. Woll M.G., Qi H., Turpoff A., Zhang N., Zhang X., Chen G., Li C., Huang S., Yang T., Moon Y.-C., Lee C.-S., Choi S., Almstead N.G., Naryshkin N.A., Dakka A., Narasimhan J., Gabbeta V., Welch E., Zhao X., Risher N., Sheedy J., Weetall M., Karp G.M. J. Med. Chem., 2016, 59 (13), 6070–6085.

25. Chen G., Dakka A., Karp G.M., Li C., Narasimhan J., Naryshkin N., Weetall, M.I., Welch E., Zhao X. Patent WO 2013112788 A1, 2013.

26. Dorsch D., Buchstaller H.-P. Patent WO201423390 A2, 2014.

27. Saeed A., Ashraf Z. Heterocycl. Comp., 2008, 44 (8), 967–972.

28. Шабликіна О.В., Іщенко В.В., Нагорна З.В., Хиля В.П. Доповіді НАН України, 2017, (2), 67–71. Shablykina О.V., Ishchenko V.V., Nagornaya Z.V., Khilya V.P. Dopov. Nac. akad. nauk Ukr., 2017, (2), 67–71.

29. Irudayanathan F.M., Noh J., Choi J., Lee S. Adv. Synth. Catal., 2014, 356 (16), 3433–3442.

30. Іщенко В.В., Шабликін О.В., Туров О.В., Шабликіна О.В., Хиля В.П. Доповіді НАН України, 2006, (4), 133–138. Ishchenko V.V., Shablykin О.V., Turov O.V., Shablykina О.V., Khilya V.P. Dopov. Nac. akad. nauk Ukr., 2006, (4), 133–138.

31. Хиля В.П., Ищенко В.В. Химия гетероциклических соединений. Современные аспекты. Ред. Карцев В.Г. М.: МБФНП, 2014, 1, 211–216. Khilya V.P., Ishchenko V.V. Chemistry of Heterocyclic Compounds. Modern Aspects. Kartsev V.G. ed. Moscow, ICSPF, 2014, 1, 211–216. (in Russian).

32. He L.-W., Chen Y.-Q., Yang J.-Y., Wang T.-L., Li W., Liu H.-Q. Molecules, 2014, 19 (12), 20906–20912.

33. Dyke S.F., Thorns J.F., Hedges S.H. Tetrahedron, 1979, 15, 1861–1867.

34. Matsuda H., Shimoda H., Yamahara J., Yoshikawa M. Bioorg. Med. Chem. Lett., 1998, 8 (3), 215–220.

35. Johnson A.T., Kaneko S., Mohan R., Oda K., Schweiger E.J. Patent WO 2004058717 A1, 2004.

36. Letourneau J., Chan J.-H., Jokiel P., Ohlmeyer M., Neagu I., Riviello C., Morphy R.J., Napier S.E., Ho K.-K. 2-(1-Oxo-1H-isoquinolin-2-yl)acetamide derivatives. Patent US 2008064678 A1, March 13, 2008

37. Roy S., Neuenswander B., Hill D., Larock R.C. J. Comb. Chem., 2009, 11, 1128–1135.

38. Tang Z., Niu S., Liu F., Lao K., Miao J., Ji J., Wang X., Yan M., Zhang L., You Q., Xiao H., Xiang H. Bioorg. Med. Chem. Lett., 2014, 24 (9), 2129–2133.

39. Dabholkar V.V., Tripath D.R. J. Heterocycl. Chem., 2011, 48 (3), 529–532.

40. Pandey V.K., Pathak L.P., Mishra S.K. Ind. J. Chem., Sect. B, 2005, 44B (9), 1940–1943.

41. Pandey V. K., Tusi S., Misra R., Shukla R. Ind. J. Chem., Sect. B, 2010, 49B (1), 107–111.

42. Singh V.K., Sharma H., Singh S.K., Gangwar L. Chem. Biol. Drug Des., 2013, 82 (1), 119–124.

43. Singh V.K., Pandey V.K. Ind. J. Chem., Sect. B, 2006, 45B (12), 2745–2748.

44. Tiwari A.K., Mishra A.K., Bajpai A., Mishra P., Sharma R.K., Pandey V.K., Singh V.K. Bioorg. Med. Chem. Lett., 2006, 16 (17), 4581–4585.

45. Roopan S. M., Sri T.R.S., Reddy B.R., Khan F.N. Ind. J. Heterocycl. Chem., 2009, 19 (1), 77–78.

46. Pandey V.-K., Joshi M., Tandon M., Bajpai S.K. Acta Pharm. (Zagreb), 2000, 50 (4), 273–280.

47. Krishnakumar V., Kumar K.M., Mandal B.K., Nawaz Khan F.-R. Scientific World J., 2012, 2012, Article ID 619080.

48. Buu-Hoi N.P. Bull. Soc. Chim. France, 1944, 11 (5), 338–342.

49. Legrand L., Lozach N. Bull. Soc. Chim. France, 1964, (8), 1787–1793.

50. Kulkarni U.S., Usgaonkar R.N. J. Indian Chem. Soc., 1991, 68 (9), 525–526.

51. Bentley K.W. The Isoquinoline Alkaloids: A Course in Organic Chemistry. Elsevier, 2014, 272 p.

52. Bailey A.S., Worthing C.R. J. Chem. Soc., 1956, 4, 4535–4543.

53. Beugelmans R., Chastanet J., Ginsburg H., Quintero-Cortes L., Roussi G. J. Org. Chem., 1985, 50 (24), 4933–4938.

54. Duval О., Mavoungou Gomиs L. Tetrahedron Lett., 1988, 29 (26), 3243–3246.

55. Ito M., Konno F., Kumamoto T., Suzuki N., Kawahata M., Yamaguchi K., Ishikawa T. Tetrahedron, 2011, 67 (41), 8041–8049.

56. Jagtap P., Baloglu E., van Duzer J. H., Szabo C., Salzman A. U.S. Patent 6,828,319, 2004.

57. Jagtap P., Baloglu E., Van Duzer J.H., Szabo C., Salzman A.L., Roy A., Williams W., Nivorozhkin A. Patent WO200582368, 2005.

58. Salzman A.L., Szabo C. Patent US200619980 (A1), 2006.

59. Cho W.-J., Le Quynh M., My V., Hue T., Youl L., Kang B.Y., Lee E.-S., Lee S.K., Kwon Y. Bioorg. and Med. Chem. Lett., 2007, 17 (13), 3531–3534.

60. Jagtap P.G., Baloglu E., Southan G.J., Mabley J.G., Li H., Zhou J., Van Duzer J., Salzman A.L., Szabo C. J. Med. Chem., 2005, 48 (16), 5100–5103.

61. Michalsky J., Hrbata J., Krepelka J., Melka M., Miko M., Hruby M., Ferenc M., Skacelov E., Kejhova I., Reichlova R.Z., Kargerova A., Sediva J., Kolonicny A., Urbanec J. Patent US5597831 (A), 1997.

62. Strumberg D., Pommier Y., Paull K., Jayaraman M., Nagafuji P., Cushman M. J. Med. Chem., 1999, 42 (3), 446–457.

63. Cushman M., Jayaraman M., Vroman J.A., Fukunaga A.K., Fox B.M. J. Med. Chem., 2000, 43 (20), 3688–3698.

64. Cushman M.S., Nagafuji P.M., Jayaraman M., Pommier Y.G. Patent US6509344 (B1), 2003.

65. Nagarajan M., Morrell A., Fort B.C., Meckley M.R., Antony S., Kohlhagen G., Pommier Y., Cushman M. J. Med. Chem., 2004, 47 (23), 5651–5661.

66. Morrell A., Antony S., Kohlhagen G., Pommier Y., Cushman M. Bioorg. Med. Chem. Lett., 2006, 16 (7), 1846–1849.

67. Morrell A., Placzek M.S., Steffen J.D., Antony S., Agama K., Pommier Y., Cushman M. J. Med. Chem., 2007, 50 (9), 2040–2048.

68. Morrell A., Placzek M.S., Parmley S., Antony S., Dexheimer T.S., Pommier Y., Cushman M. J. Med. Chem., 2007, 50 (18), 4419–4430.

69. Ryckebusch A., Garcin D., Lansiaux A., Goossens J.-F., Baldeyrou B., Houssin R., Bailly C., Henichart J.-P. J. Med. Chem., 2008, 51 (12), 3617–3629.

70. Kim S.H., Oh S.M., Song J.H., Cho D., Le Q.M., Lee S.-H., Cho W.-J., Kim T.S. Bioorg. Med. Chem. Lett., 2008, 16 (3), 1125–1132.

71. Ahn G., Lansiaux A., Goossens J.-F., Bailly C., Baldeyrou B., Schifano-Faux N., Grandclaudon P., Couture A., Ryckebusch A. Bioorg. Med. Chem. Lett., 2010, 18 (22), 8119–8133.

72. Bejugam M., Gunaratnam M., Mueller S., Sanders D.A., Sewitz S., Fletcher J.A., Neidle S., Balasubramanian S. ACS Med. Chem. Lett., 2010, 1 (7), 306–310.

73. Chen L., Conda-Sheridan M., Reddy P.V.N., Morrell A., Park E.-J., Kondratyuk T.P., Pezzuto J.M., Van B., Richard B., Cushman M. J. Med. Chem., 2012, 55 (12), 5965–5981.

74. Nguyen T.X., Morrell A., Conda-Sheridan M., Marchand C., Agama K., Bermingam A., Stephen A.G., Chergui A., Naumova A., Fisher R., O'Keefe B.R., Pommier Y., Cushman M. J. Med. Chem., 2012, 55 (9), 4457–4478.

75. Conda-Sheridan M., Reddy P.V.N., Morrell A., Cobb B.T., Marchand C., Agama K., Chergui A., Renaud A., Stephen A.G., Bindu L.K., Pommier Y., Cushman M. J. Med. Chem., 2013, 56 (1), 182–200.

76. Cushman M.S., Nguyen T.X., Conda-Sheridan M.M. Patent US2013345252, 2013.

77. Pham Thi T., Le Nhat T.G., Ngo Hanh T., Luc Q.T., Pham The C., Dang Thi T.A., Nguyen H.T., Nguyen T.H., Hoang Thi P., Van Nguyen T. Bioorg. Med. Chem. Lett., 2016, 26 (15), 3652–3657.

78. Thi T.P., Decuyper L., Quang T.L., The C.P., Dang T., Tuyet A., Nguyen H.T., Le Nhat T.G., Thanh T.N., Thi P.H., D'Hooghe M., Van Nguyen T. Tetrahedron Lett., 2016, 57 (4), 466–471.

79. Wambang N., Schifano-Faux N., Aillerie A., Baldeyrou B., Jacquet C., Bal-Mahieu C., Bousquet T., Pellegrini S., Ndifon P.T., Meignan S., Goossens J.-F., Lansiaux A., Pélinski L. Bioorg. Med. Chem., 2016, 24 (4), 651–660.

80. Peterson K.E., Cinelli M.A., Morrell A.E., Mehta A., Dexheimer T.S., Agama K., Antony S., Pommier Y., Cushman M. J. Med. Chem., 2011, 54 (14), 4937–4953.

81. Beck D.E., Agama K., Marchand C., Chergui A., Pommier Y., Cushman M. J. Med. Chem., 2014, 57 (4), 1495–1512.

82. Nagarajan M., Morrell A., Antony S., Kohlhagen G., Agama K., Pommier Y., Ragazzon P.A., Garbett N.C., Chaires J.B., Hollingshead M., Cushman M. J. Med. Chem., 2006, 49 (17), 5129–5140.

83. Cushman M.S., Morrell A., Nagarajan M., Pommier Y.G. Patent WO200759008 (A2), 2007.

84. Merchantz J.R., Koshti N.M., Bakre K.M. J. Het. Chem., 1981, 18 (8), 1655–1658.

85. Chatterjea J.N., Banerjee B.K., Prasad N. J. Indian Chem. Soc., 1965, 42, 283–288.

86. Yamaguchi S., Uchiuzoh Y., Sanada K. J. Het. Chem, 1995, 32 (2), 419–423.

87. Шабликіна О.В., Савченко В.В., Іщенко В.В., Хиля В.П. Укр. хім. журн., 2017, 83 (2), 109–114. Shablykina O.V., Savchenko V.V., Ishchenko V.V., Khilya V.P. Ukr. Khim. Zh., 2017, 83 (2), 109–114.

88. Cushman M., Jayaraman M., Vroman J.A., Fukunaga A.K., Fox B.M., Kohlhagen G., Strumberg D., Pommier Y. J. Med. Chem., 2000, 43 (20), 3688–3698.

89. Matteucci M., Duan J.-X., Rao P. Patent WO2006065448 (A2), 2006.

90. Wölbling H. Chem. Ber., 1905, 38 (4), 384–3853.

91. Lieck. Chem. Ber., 1905, 38 (4), 3854–3856.

92. Buu-Hoi, N.P. Phenolhomophthalein. C. R. Hebd. Seances Acad. Sci., 1939, 209, 321–324.

93. Kharaneko O.I., Popov V.Y., Bogza S.L. Chem. Heterocycl. Comp., 2013, 49 (2), 317–324.

94. Legrand L., Lozac'h N. Bull. Soc. Chim. France, 1970, 2227–2232.

95. Lu S., Lin Y., Zhong H., Zhao K., Huang J. Tetrahedron Lett., 2013, 54 (15), 2001–2005.

96. Ivanchikova I.D., Myasnikova R.N., Shvartsberg M.S. Russ. Chem. Bull., 1998, 47 (10), 1975–1979.

97. Dusemund J. Arch. Pharm., 1982, 315 (11), 925–930.

98. Dusemund J. Arch. Pharm., 1983, 316 (2), 110–114.

99. Bishnoi A., Saxena R., Srivastav K., Joshi M.N., Bajpai S.K. Indian J. Heterocycl. Chem., 2006, 15 (3), 307–308.

100. Pandey V.K., Shukla A. Synthesis and biological activity of isoquinolinyl benzimidazoles. Indian J. Chem. Sect. B., 1999, 38B (12), 1381–1383.

Published

2018-04-13

How to Cite

USING OF 3-ARYLISOCOUMARINS IN 3-ARYLISOQUINOLONS SYNTHESIS: UDC 547.814.5, 547.833.7. (2018). Bulletin of the Taras Shevchenko National University of Kyiv. Chemistry, 54(2), 18-30. https://chemistry.bulletin.knu.ua/article/view/8450

Most read articles by the same author(s)

<< < 1 2